Provided by Tiger Trade Technology Pte. Ltd.

Redhill Biopharma

0.5390
-0.0390-6.75%
Post-market: 0.5240-0.0150-2.78%18:53 EDT
Volume:380.16K
Turnover:209.06K
Market Cap:3.28M
PE:-3.97
High:0.5917
Open:0.5450
Low:0.5200
Close:0.5780
52wk High:2.14
52wk Low:0.4351
Shares:6.08M
Float Shares:6.08M
Volume Ratio:0.12
T/O Rate:6.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1358
EPS(LYR):-0.1358
ROE:-1708.61%
ROA:-22.37%
PB:-3.04
PE(LYR):-3.97

Loading ...

RedHill Biopharma Wins NASDAQ Extension to Regain $1 Minimum Bid Compliance by April 5, 2027

Reuters
·
Oct 07

Redhill Biopharma H1 2026 EPS $0.00 And Revenue $0.00

Benzinga Earnings
·
Oct 01

RedHill Biopharma Sells 70% Stake in Talicia Holdings to Apotex for USD 18 Million Upfront

Reuters
·
Oct 01

RedHill Biopharma Net Loss Widens 48% to USD 6.1 Million in First Half 2026

Reuters
·
Oct 01

Press Release: RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results

Dow Jones
·
Oct 01

RedHill announces acquisition of commercialization rights to Rebyota, Clenpiq

TIPRANKS
·
Sep 01

Press Release: RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota(R) and Clenpiq(R)

Dow Jones
·
Sep 01

NASDAQ Trade Halt Volatility Trading Pause at 09:36 Am

Reuters
·
Aug 31

RedHill Biopharma Sells Talicia Stake to Apotex for $18 Million Upfront

Reuters
·
Aug 31

Press Release: RedHill Divests Talicia(R) to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

Dow Jones
·
Aug 31

NASDAQ Trade Halt Halt News Pending at 06:57 Am

Reuters
·
Aug 31

RedHill Biopharma Releases Corporate Presentation Outlining Talicia Commercialization, Late-stage Pipeline Progress

Reuters
·
Aug 03

Redhill Biopharma Delays Annual Shareholder Meeting to Aug. 6 to Add Proposal to Proxy Materials

Reuters
·
Jul 01

Redhill Biopharma Ups Maximum Size of H.C. Wainwright-led ATM ADS Offering

Reuters
·
Jun 29

RedHill Biopharma Closes Private Placement

MT Newswires Live
·
Jun 23

RedHill Biopharma prices $6 million private placement of ADSs at $0.7 each

Reuters
·
Jun 23

RedHill Biopharma prices $6 million private placement at $0.70 per ADS

Reuters
·
Jun 18

Press Release: RedHill Biopharma Announces Up To $19.4 Million Private Placement

Dow Jones
·
Jun 18

RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside

TIPRANKS
·
Jun 16

RedHill Biopharma posts corporate presentation on Talicia commercialization and GI-focused pipeline

Reuters
·
Jun 15